A nasolacrimal stent is considered to be a small tube used to treat conditions like epiphora and intended for use in dacryocystorhinostomy (DCR) and congenital nasolacrimal obstruction as well. Growing prevalence of nasolacrimal duct obstruction (NLDO), a common syndrome of lacrimal system, is expected to drive growth of nasal lacrimal stent market. For instance, in 2019, according to data published by the NCBI (National Center for Biotechnology Information), the prevalence for nasolacrimal duct obstruction has found around 6% to 20% in global infants.
Download the Sample copy Of Report with Table of Contents and Figures @ https://www.coherentmarketinsights.com/insight/request-sample/3183
Nasal Lacrimal Stent Market- Drivers
The nasal lacrimal stent market size is expected to increase over the forecast period owing to ongoing research on products to treat Epiphora and Dacryocystorhinostomy disease conditions. For instance, October 2019, Alon Kahana from University of Michigan sponsored a study aimed to evaluate safety and efficacy of the slit stent ii lacrimal stent for treatment of nasolacrimal duct obstruction.
Furthermore, availability of advanced products is expected to drive growth of this market. The FCI Ophthalmics Company offers products such as Nunchaku and BIKA intubation system, a bicanalicular stent which is used to drain tears by capillary.
Get your Customized Research Report: https://www.coherentmarketinsights.com/insight/request-customization/3183
Nasal Lacrimal Stent Market- Restraints
Alternative treatment available for epiphora medical conditions is major restraining factor of nasal lacrimal stent market. Most pharmaceuticals companies are focused on developing promising drugs which are indicated for treatment of ophthalmic diseases.
Nasal Lacrimal Stent Market- Regional Analysis
On the basis of region, the nasal lacrimal stent market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the nasal lacrimal stent market during the forecast period, as key market players are focused on expanding their presence in the North America region. For instance, in Jan, 2019, FCI Ophthalmics entered an agreement with Carl Zeiss Canada Ltd. regarding the distribution of FCI Ophthalmics’ range of lacrimal stents and tubes, which include Crawford & Ritleng, Mini Monoka & new Masterka (monocanicular stent), Bika & Nunchaku (Bicanicular stent) in Canada.
Nasal Lacrimal Stent Market- Competitive Landscape
Key players operating in the nasal lacrimal stent market include FCI Ophthalmics, Kaneka Corporation, Cook Medical LLC., and Sinopsys Surgical, Inc.
Buy This Premium Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3183
Nasal Lacrimal Stent Market- Taxonomy
The nasal lacrimal stent market is segmented on the basis of product type, application, end-user, and region
By Product Type
- Bicanalicular Stents
- Monocanalicular Stents
By Application
- Epiphora
- Dacryocystorhinostomy (DCR)
- Congenital nasolacrimal obstruction
By End-User
- Hospitals
- Ophthalmic Surgery Centers
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
sales@coherentmarketinsights.com
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
